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not, the meat-to-bone yields that bob
calves lack, and the relatively low price

makes the product a nutritional and affordable choice for the consumer.
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Under the Animal Welfare Act:
Their Inadequacies and the
Public's Right to Know
M. Solomon

and
P.C. Lovenheim
Introduction
The Animal Welfare Act is the only
federal statute designed to protect animals used in laboratory research. Under
this law, research facilities are required
to register with the U.S. Department of
Agriculture (USDA) and to meet minimum
standards of housing, care, and treatment
for most warm-blooded animals. The Act
is administered by the Animal and Plant
Health Inspection Service (APHIS), an
agency of the USDA.
The Animal Welfare Act established by law

The human ethic that animals should
be accorded the basic creature comforts of adequate housing, ample
food and water, reasonable handling, decent sanitation, sufficient
ventilation, shelter from extremes
of weather and temperature, and

adequate veterinary care, including
the appropriate use of pain-killing
drugs. [emphasis added]
The petitioner considers all provisions of the Animal Welfare Act important, but none more so than those that
concern animals used in painful experimentation. The number of animals used
in such procedures is great, and has increased over the years from 65,301 in
1974 to 122,650 in 1980, according to
APHIS (1975, 1981) reports. (These figures
are cited for comparative purposes only
since their reliability is questionable.)
- Since 1970, congress has required
research facilities to show that during actual research and experimentation, painrelieving drugs are used "appropriately"
and in accordance with "professionally
acceptable standards" of care. To this
end, congress established the Research
Facility Annual Reporting System.

Mark Solomon is a student at the University of Virginia Law School, Charlottesville, VA. Peter Lovenheim is
an attorney who is HSUS Counsel for Government and Industry Relations, 2100 L Street, NW, Washington,
DC 20037. This article is adapted from a petition for rulemaking filed by The HSUS with the USDA on February 22, 1982.
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/T]he Secretary [of Agriculture] shall
require, at least annually, every research facility to show that professionally acceptable standards governing the care, treatment, and use
of animals, including appropriate use
of anesthetic, analgesic, and tranqu if iz ing drugs, during experimentation are being followed by theresearch facility during actual research
or experimentation (7 USC 2143emphasis added).
Under current regulations, research
facilities must file an Annual Report
with APHIS showing the number of types
of animals used in "actual research,
testing, or experimentation," and indicating which tests involved "accompanying
pain or distress to the animals." In instances when animals were used in painful procedures but were given no painrelieving drugs, the Annual Report must
include "a brief statement explaining
the reasons for the same" (9 CFR 2.28 (a)
(2}-(4)).
The Reporting System, functioning
properly, should provide APHIS with information sufficient to demonstrate that
researchers are using pain-relieving drugs
"appropriately" and in accordance with
"professionally acceptable standards."
This was congress' intent and the System
is, in fact, the only means by which APHIS
can obtain such information on a regular
and cost-effective basis. Effective administration of the Reporting System,
therefore, is crucial to enforcement of
this most important provision of the Animal Welfare Act. We therefore undertook
an analysis of the reports_ from 1 ,211
facilities for FY 1979.
We conclude from the analysis that
the Reporting System, as presently administered, fails to achieve its primary
statutory objective: it does not provide
APHIS with information sufficient to
demonstrate that researchers have used
pain-relieving drugs "appropriately" and
/NT 1 STUD AN/M PROB 3(3) 1982

in accordance with "professionally acceptable standards." The chief reasons
for this failing are (1) regulations and
guidelines do not define "pain" or "distress," (2) regulations and guidelines do
not adequately define "routine procedures," and (3) regulations and guidelines
do not require meaningful explanations
for the withholding of pain-relieving
drugs in procedures acknowledged to
cause pain.
The Reporting System, as presently
administered, for the same reasons, also
fails to achieve a secondary- but nonetheless important- objective: it does not
generate reliable and meaningful information to the public about the use of animals in research. When congress passed
the Animal Welfare Act amendments in
1970, it declared that animals used in research "deserve the care and protection
of a strong and enlightened public" (H.
Rep. No. 91-1651, 91 st Cong., reprinted in,
(1970) U.S. Code Cong. & Ad. News 5103,
5104- emphasis added). The analysis also revealed serious transcription errors,
involving tens of thousands of animals,
by APHIS staff.

Statement of the Problem
Current regulations and guidelines
do not define "pain" or "distress."
Without such definitions, researchers
appear to apply conflicting standards \
in interpreting these terms.
Current regulations require research
facilities to report annually to APHIS on
the use of animals in "actual research,
testing, or experimentation," and to indicate which tests involved "accompanying pain or distress to the animals" (9
CFR 2.28(a)). APHIS supplies researchers
with a specific form for submitting the
Annual Report ("Annual Report of Research Facility," VS Form 18-23) and has
also issued instructions for completing
the Report form ("Instructions for Submitting the Research Facility Annual Re211
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port Form," VS Memo. 595.19) (1975) the animal may experience pain or dis(Appendix B)).
tress."
In contrast, Revlon Research CenThe Report form is organized by species of animal covered by the Animal ter, Inc. (Reg. No. 21-43) of Bronx, NY,
Welfare Act and by type of experiment. reported that 2,371 guinea pigs and
Experiments fall into three categories (in 2,210 rabbits were used in "Draize Eye
Category A, the species used is identified): Irritation Studies" and "Primary Skin Irritation Studies" and yet listed all aniCategory 8: Experiments or tests in- mals in Column B-"No Pain."
volving no pain or distress
A more ambiguous approach was
Category C: Experiments or tests inreflected by the Report of ALZA Corp.
volving pain or distress where appropriate
(Reg. No. 93-56) of Palo Alto, CA, which
anesthetic, analgesic, or tranqu i I izers
listed all of the animals it used in Colwere used
umns B or C. The report stated that ALZA
Category 0: Experiments or tests inused New Zealand white rabbits "to
volving pain or distress but where anesstudy potential ocular and/or cutaneous
thetic, analgesic, or tranquilizers were
compounds." The company explained that
not used.
the use of pain-relieving drugs would
Clearly, a registrant's determination "preclude meaningful interpretation of
as to whether an animal was caused "pain" these test results," and that the animals
or "distress" is essential to the proper did not undergo "procedures of an
completion of the Annual Report form. acutely painful nature requiring chemical
However, neither the regulations, nor the restraint or analgesia." The former stateAPHIS instructional memorandum, nor ment suggests drugs were indicated; the
the Annual Report form itself defines latter denies their necessity. The explanation continued, "Therefore, due to
these terms.
The result is that research facilities the experimental nature of the work, the
appear to apply different and conflict- number of rabbits experiencing pain or
ing standards in assessing the responses distress would be difficult to determine
of animals used in similar procedures. or construe in the given context." However, after having explained how and
Two examples are discussed below.
why pain-relieving drugs were not used,
180 rabbits were listed in Column C1. Eye and skin irritation studies
"Pain and Drugs," and 397 rabbits were
The Monsanto Company (Reg. No.
listed in Column B- "No Pain." No ani43-33), of St. Louis, MO, which performs
mals were listed in Column D.
eye and dermal testing of products, reported that it used 1,044 rabbits in Col- 2. Pyrogen testing
umn D of the form, "Pain-No Drugs,"
Pyrogen testing is the screening for
and explained: "These studies by their preparations that might raise body temnature cause distress to the rabbits." perature to a dangerous degree. Ortho
Similarly, Unilab Research (Reg. No. 93- Diagnostics, Inc. (Reg. No. 22-64) of
154) of Berkeley, CA, reported eye and Raritan, NJ. listed 819 rabbits in Column
skin irritation studies in 1,150 rabbits, 50 B ("No Pain") and explained "Animals
of which were listed in Column D. The are used for antibody production and
explanation attached to the Annual Re- pyrogen testing. When euthanized, apport stated: "Some materials, based on propriate drugs are used." Similarly, Burthe response in the test animals, are ron Medical Products, Inc. (Reg. No 23-59)
classified as 'corrosive.' During exposure of Bethlehem, PA, listed 250 rabbits in
to these corrosive substances, and dur- Column B and explained, "Pyrogen and
ing the subsequent evaluation period, lntacutaneous [sic] Reactivity Testing as
212
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per USP XIX does not involve pain or distress to the rabbits."
In contrast, John Hopkins University
(Reg. No. MD-R-11) of Baltimore, MD,
listed 300 rabbits in Column D- "Pain-No
Drugs." The explanation attached to the
Report stated: "Anesthesia not used for
intravenous or interperitoneal injections
or for pyrogen assay. Anesthetics would
inhibit the response to pyrogens."
The test procedures discussed (eye
and skin irritation, and pyrogen testing)
were evaluated by the different registrants
as causing differing amounts of pain and/or
discomfort. The same protocols were used,
and in many cases similar substances
were introduced into test animals, yet
there are inconsistencies among facilities in regard to the research category
chosen on the Annual Report. Anecdotal
evidence obtained by us provides further examples of inconsistency. For example, Dr. G.L. Enold, DVM, Director of
Veterinary Medicine at ICI Americas,
Inc., in a telephone conversation on February 4, 1981, bluntly told one of us (M.S.)
that a// toxicology work falls within the
"No-Pain" classification. Dr. Enold's remark may have been in reference to
work conducted at ICI Americas only,
but even if that were the case, his statement would constitute a rather sweeping proclamation.
The inconsistencies surrounding the
definition of "pain" and "distress" are
further complicated by the current definition of "routine procedures," a problem that is addressed below.

The current definition of "routine
procedures" is inadequate, as evidenced by inconsistent application
of the exemption by both researchers and APHIS officials.
Current regulations provide that
"routine procedures" performed on animals do not have to be reported on Annual Report forms. Regulations do not
formally define "routine procedures,"
but offer three examples of procedures
that are intended to fit into this category:
/NT 1 STUD ANIM PROB 3(3) 1982

Comment

"injections, tattooing, and blood sampling" (9 CFR 2.28(a) (2)-(4)). Neither the
APHIS instructional memorandum nor the
Annual Report form itself offers further
guidance as to how this term is to be applied, and a large number of cases were
found in which the "routine procedures"
exemption was inconsistently applied.
For example, challenge testing involves the injection of a vaccine or bacterin into a group of animals followed
by injection of a selected disease agent
to determine whether the animal has
been immunized. (A control group receives the virus or bacteria, but not the
vaccine or bacterin.) The cases discussed below involve challenge testing for
Leptospira bacterin. Quoted statements
are from the registrants' 1979 Annual Reports.
In the first case, Burns Biotec Laboratories, Inc. (Reg. No. 47-10) of Elkhorn,
NE, listed 1,275 hamsters used in challenge testing. Though the bacterin was
administered by injection, the registrant
evidently did not consider this a "routine
procedure" and listed all the animals in
Column D- "Pain-No Drugs." The report explained, "The hamsters were used
in Leptospira bacterin potency tests according to applicable 9 CFR 113 methods and for maintenance of Leptospira
challenge cultures."
The second case in point concerns
Jensen-Salsbery Laboratories, a division
of Burroughs Wellcome (Reg. No. 48-12),
of Kansas City, KS. In 1979, this registrant
reported that it had used more than
32,000 animals in various types of challenge testing. This included 15,868 hamsters used in Leptospira challenge tests,
just as Burns Biotec (noted above) had
done. As noted by Solomon (1981 ), the
1979 annual report had been altered so
that the numbers of animals listed as
having been used under Category D"Pain-No Drugs"- had been moved into
Category C- "Pain and Drugs." Solomon
stated that:
213
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When informed of the discrepancy,
Mr. ).A. McKeown, Production Manager and signatory on the report,
stated that he had not changed the
reports and had not been told by
the USDA of any alterations. The
USDA, responding to further enquiries, provided the following information.
In late 1979 or early 1980, Dr.
Robert Whiting, then USDA-APHIS
Chief Staff Veterinarian, contacted
his area office in Kansas to enquire
about the )ensen-Salsbery reports.
After consulting with that office,
Dr. Whiting relisted the numbers
from Column D to Column C. He justified the action by referring to information he obtained from attachments to the reports, which ... were
of "challenge testing" .... Dr. Whiting
(personal communication- March
25, 1981) reasoned that because the
tests involved injections, which are
considered under the regulations to
be routine procedures, there was no
need to report them. He added that
he felt the research facilities had misinterpreted or were unaware of the
exemption. Dr. Whiting maintained
that these particular inoculations
cause, at most, only minor and temporary pain although he did concede
that the infections induced in the
control group, as well as in those
animals that might receive an ineffective vaccine or bacterin, could
cause considerable pain.
The disease agents used in the )ensen-Salsbery challenge tests were
Leptospira, rabies virus and anaerobic bacteria. The attachments to the
reports note specifically that in each
instance, no pain-relieving drugs were
administered. Mr. McKeown assumed
that infections which cause pain
and distress in untreated humans
cause similar pain and distress in
214

Comment

untreated laboratory animals. Therefore, to comply with regulations,
)ensen-Salsbery listed the animals
in Column D.
The cases discussed above illustrate
the practical problems that can result
from the current definition of "routine
procedures."

Some registrants provide no explanation for withholding pain-relieving drugs; others merely parrot
language suggested by USDA, providing explanations that are perfunctory and unrevealing.

M Solomon & P. C. Lovenheim

Further information for completing
Column D is provided in the APHIS instruction memorandum:

List the number of animals used
where pain or distress was involved
but where anesthetic, analgesic, or
tranquilizing drugs were not used.
A brief explanation why drugs were
not used must be attached, e.g., testing of toxic products required by
FDA, use of anesthetic, analgesic,
or tranquilizing drugs would interfere
with test results. Many other reasons in addition to this may be listed
(VS Memo. 595.19 (1975) at p. 4).

By law, research facilities must show
that during actual testing on animals,
pain-relieving drugs are used "appropriately" and in accordance with "professionally acceptable standards" (7 USC
2143). Current regulations require Annual
Reports to I ist:

The common names and approximate number of animals upon which
experiments ... were conducted involving accompanying pain or distress ... and for which the use of
[pain-relieving drugs/ would adversely affect the procedures ... and
a brief statement explaining the reasons for the same (9 CFR 2.28(a) (4)).
As the regulation indicates, pain-relieving drugs may be withheld from animals only if use of such drugs would
"adversely affect" the test procedures.
By explaining how this standard ("adversely affect") applies to each procedure, researchers can fulfill the statutory
requirement of "showing" that professionally acceptable standards have been
followed.
Animals used in painful tests without pain-relieving drugs are listed on the
Annual Report form in Column D"Pain-No Drugs." An instructional note
at the head of Column D asks researchers to "Attach a brief explanation."
/NT I STUD ANIM PROB 3(3) 1982

Several problems are associated with
this aspect of the Reporting System. Two
of these are:

1. Failure to provide an explanation
The analysis revealed that a number of registrants recorded totals of animals in Column D- "Pain-No Drugs,"
but provided no explanation as to why
pain-relieving drugs had been withheld.
Nineteen facilities in 12 states using a
total of 7,483 animals gave no explanations to accompany their Column D listings, and thus were in technical violation
of reporting requirements (Table 1 ).

2. Use of inadequate explanation
Some research facilities also attempt to explain the withholding of
pain-relieving drugs by merely parroting
the suggested "explanations" offered by
APHIS in its instructional memorandum.
These "explanations" are: "testing of
toxic products required by FDA," and
"use of anesthetic, analgesic, or tranquilizing drugs would interfere with test results" (VS Memo. 595.19 (1975) at p. 4).
The parroting of these "explanations"
is a serious problem, not only because
they are so perfunctory and unrevealing,
but because they do not "show," as re/NT I STUD ANIM PROB 3(3] 1982

Comment

quired by law, that pain-relieving drugs
have been used "appropriately" and in
accordance with "professionally acceptable standards."
A conservative analysis of all explanations contained in or attached to
1979 Annual Reports shows that 31 facilities in 9 states that listed 27,331 animals
in Column D- "Pain-No Drugs," used
the exact explanations or wording that
was very similar to that suggested in the
APHIS instructional memorandum. In addition, research facilities using 7,483 animals in FY 1979 offered no explanation
for withholding pain-relieving drugs
from animals. The total number of animals used in painful research without
sufficient explanation, therefore, was
more than 34,800- a figure equal to approximately 32 percent of all animals
reported to have been used that year in
painful research without drugs.

Legal Considerations
Present administration of the research facility annual reporting system violates both the letter and intent of the Animal Welfare Act.
The original Animal Welfare Act of
1966 exempted from regulation the use
of animals during actual research (80
Stat. 350, Sec.18). In a Report accompanying the Act, congress stated that the determination as to when an animal is "in
actual research" should be left to researchers to decide "in good faith" (S.
Rep. No. 1281, 89th Con g., reprinted in
(1966) U.S. Code Cong. & Ad. News 2635,
2639).
In 1970, a unanimous House Agriculture Committee added the assurance
that "the research scientist still holds
the key to the laboratory door" (H. Rep.
No. 91-1651, 91st Cong., reprinted in (1970)
U.S. Code Cong. & Ad. News 5103, 5104).
Yet, in 1970, two important new elements emerged from congress' efforts to
strengthen the Act.
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When informed of the discrepancy,
Mr. ).A. McKeown, Production Manager and signatory on the report,
stated that he had not changed the
reports and had not been told by
the USDA of any alterations. The
USDA, responding to further enquiries, provided the following information.
In late 1979 or early 1980, Dr.
Robert Whiting, then USDA-APHIS
Chief Staff Veterinarian, contacted
his area office in Kansas to enquire
about the )ensen-Salsbery reports.
After consulting with that office,
Dr. Whiting relisted the numbers
from Column D to Column C. He justified the action by referring to information he obtained from attachments to the reports, which ... were
of "challenge testing" .... Dr. Whiting
(personal communication- March
25, 1981) reasoned that because the
tests involved injections, which are
considered under the regulations to
be routine procedures, there was no
need to report them. He added that
he felt the research facilities had misinterpreted or were unaware of the
exemption. Dr. Whiting maintained
that these particular inoculations
cause, at most, only minor and temporary pain although he did concede
that the infections induced in the
control group, as well as in those
animals that might receive an ineffective vaccine or bacterin, could
cause considerable pain.
The disease agents used in the )ensen-Salsbery challenge tests were
Leptospira, rabies virus and anaerobic bacteria. The attachments to the
reports note specifically that in each
instance, no pain-relieving drugs were
administered. Mr. McKeown assumed
that infections which cause pain
and distress in untreated humans
cause similar pain and distress in
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untreated laboratory animals. Therefore, to comply with regulations,
)ensen-Salsbery listed the animals
in Column D.
The cases discussed above illustrate
the practical problems that can result
from the current definition of "routine
procedures."

Some registrants provide no explanation for withholding pain-relieving drugs; others merely parrot
language suggested by USDA, providing explanations that are perfunctory and unrevealing.
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Further information for completing
Column D is provided in the APHIS instruction memorandum:

List the number of animals used
where pain or distress was involved
but where anesthetic, analgesic, or
tranquilizing drugs were not used.
A brief explanation why drugs were
not used must be attached, e.g., testing of toxic products required by
FDA, use of anesthetic, analgesic,
or tranquilizing drugs would interfere
with test results. Many other reasons in addition to this may be listed
(VS Memo. 595.19 (1975) at p. 4).

By law, research facilities must show
that during actual testing on animals,
pain-relieving drugs are used "appropriately" and in accordance with "professionally acceptable standards" (7 USC
2143). Current regulations require Annual
Reports to I ist:

The common names and approximate number of animals upon which
experiments ... were conducted involving accompanying pain or distress ... and for which the use of
[pain-relieving drugs/ would adversely affect the procedures ... and
a brief statement explaining the reasons for the same (9 CFR 2.28(a) (4)).
As the regulation indicates, pain-relieving drugs may be withheld from animals only if use of such drugs would
"adversely affect" the test procedures.
By explaining how this standard ("adversely affect") applies to each procedure, researchers can fulfill the statutory
requirement of "showing" that professionally acceptable standards have been
followed.
Animals used in painful tests without pain-relieving drugs are listed on the
Annual Report form in Column D"Pain-No Drugs." An instructional note
at the head of Column D asks researchers to "Attach a brief explanation."
/NT I STUD ANIM PROB 3(3) 1982

Several problems are associated with
this aspect of the Reporting System. Two
of these are:

1. Failure to provide an explanation
The analysis revealed that a number of registrants recorded totals of animals in Column D- "Pain-No Drugs,"
but provided no explanation as to why
pain-relieving drugs had been withheld.
Nineteen facilities in 12 states using a
total of 7,483 animals gave no explanations to accompany their Column D listings, and thus were in technical violation
of reporting requirements (Table 1 ).

2. Use of inadequate explanation
Some research facilities also attempt to explain the withholding of
pain-relieving drugs by merely parroting
the suggested "explanations" offered by
APHIS in its instructional memorandum.
These "explanations" are: "testing of
toxic products required by FDA," and
"use of anesthetic, analgesic, or tranquilizing drugs would interfere with test results" (VS Memo. 595.19 (1975) at p. 4).
The parroting of these "explanations"
is a serious problem, not only because
they are so perfunctory and unrevealing,
but because they do not "show," as re/NT I STUD ANIM PROB 3(3] 1982
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quired by law, that pain-relieving drugs
have been used "appropriately" and in
accordance with "professionally acceptable standards."
A conservative analysis of all explanations contained in or attached to
1979 Annual Reports shows that 31 facilities in 9 states that listed 27,331 animals
in Column D- "Pain-No Drugs," used
the exact explanations or wording that
was very similar to that suggested in the
APHIS instructional memorandum. In addition, research facilities using 7,483 animals in FY 1979 offered no explanation
for withholding pain-relieving drugs
from animals. The total number of animals used in painful research without
sufficient explanation, therefore, was
more than 34,800- a figure equal to approximately 32 percent of all animals
reported to have been used that year in
painful research without drugs.

Legal Considerations
Present administration of the research facility annual reporting system violates both the letter and intent of the Animal Welfare Act.
The original Animal Welfare Act of
1966 exempted from regulation the use
of animals during actual research (80
Stat. 350, Sec.18). In a Report accompanying the Act, congress stated that the determination as to when an animal is "in
actual research" should be left to researchers to decide "in good faith" (S.
Rep. No. 1281, 89th Con g., reprinted in
(1966) U.S. Code Cong. & Ad. News 2635,
2639).
In 1970, a unanimous House Agriculture Committee added the assurance
that "the research scientist still holds
the key to the laboratory door" (H. Rep.
No. 91-1651, 91st Cong., reprinted in (1970)
U.S. Code Cong. & Ad. News 5103, 5104).
Yet, in 1970, two important new elements emerged from congress' efforts to
strengthen the Act.
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First, the unanimous house Committee boldly declared that laboratory animals deserve the care and protection of
"a strong and enlightened public" (H.
Rep. 91-1651, 91st Cong., reprinted in
(1970) U.S. Code Cong. & Ad News 5103,
1504). Second, congress expanded the
definition of "adequate veterinary care"
to include "appropriate use" of pain-relieving drugs during "actual research
and experimentation" (84 Stat. 1560,
Sec. 14). Further, every research facility
would not be required "to show annually"
in a report to the Secretary of Agriculture
that "professionally acceptable standards"
of care are followed in the administration of pain-relieving drugs (84 Stat .
1560, Sec. 14).
Thus, the "good faith" of the 1966
Act was replaced in 1970 by an Annual
Reporting system that had at least two
important functions: (1) to provide researchers with a means to demonstrate
that pain-relieving drugs are used appropriately and in accordance with professional standards, and (2) to further
"enlighten" the public about the use of
animals in biomedical research. To be
sure, the researcher still "holds the key"
to the laboratory door, but by virtue of
the 1970 amendments, that door was intended to have a "window" in it.
However, administration of the Reporting System is flawed to the extent
that neither of these two goals can be
met at present. Without adequate definitions of "pain," "distress," and "routine
procedures," researchers cannot be said
"to show" that pain-relieving drugs are
used appropriately. Researcher's parroting of stock phrases supplied by APHIS
to explain withholding of pain-relieving
drugs compounds the problem.
The Reporting System's secondary
goal-to "enlighten" the public-is also hampered by these flaws. As long as
key terms remain undefined, data gathered from Annual Reports will remain
unreliable and misleading. Explanations
for withholding of drugs could provide
/NT 1 STUD ANIM PROB 3(3) 1982

the public with important information
about how animals are used in research.
Instead, the mere repetition of stock
phrases reveals little of substance.
Nearly 12 years after passage of the
amendment, the USDA has not set any
standards or guidelines for terms as
crucial to the Reporting System as "pain"
and "distress" (9 CFR Sec. 1.1(a)-(rr); VS
Memo. 595.19 (1975)). Researchers can
hardly be expected to demonstrate that
pain-relieving drugs have been used in
"painful experimentation" if there is no
generally accepted definition of what a
painful experiment is. This analysis clearly
reveals that researchers performing similar procedures on similar test animals
apply different and conflicting standards
to determine pain or distress, and categorize animals differently on Annual Report forms, according to their own definitions. The result is that statistical data
derived from Annual Reports are unreliable and cannot accurately reflect the
use of animals in research.
The current state of scientific knowledge does not permit the setting of an
all-encompassing, definitive standard
for "pain" and "distress." Nevertheless,
changes in regulations and guidelines
can enhance the reliability and value of
the Reporting System. The term "routine
procedures" is also a crucial one in the
Reporting scheme, for any procedure
deemed to be "routine" is automatically
exempt from all reporting requirements.
(This procedure, in addition to the fact that
rats and mice are excluded from thereporting requirements, explains why APHIS
figures are so low.) The study by The Humane Society of the U.S. has revealed
that, while some definition has been
given this term, "routine,'~ it is inadequate
to assure uniform application. Indeed,
the examples discussed earlier show that
even among APHIS officials, there is disagreement as to whether some common
test procedures are "routine" or not.
217

M Solomon & P. C. Lovenheim
-c

~

~

QJ

E ;;::,

.. ."'
-zE

~

·o.OD
"'QJ

~

:::J
OD

'§_

..Q ·-

E ~

00'"1
N 0'"1

z"'-c

li1
N
li1

Q.

"'c

"'
E

.!::

Qi

QJ

:::J
OD

0

..;-

0

N

""

N

.0

..;-

""
+
co

9

"

..;-

0

0

..c

"'
E

"'

..0

.c

u
c

~"0
·c ~

~u

E ..':

·v; u

0

~

-

QJ

.:::

·c.

OJ

~;;;

~
c
'::i

rn
E

. "'

tU

c

~

OD

E

::::s_

QJ
r:r:

c

>-

OD

-~

-

_cz

0

·u;

X

c~

Q:;-

QJ

.~ ~

0 0

"'

~

-..a
0 QJ

> 0
·- u
c c

:::J

~~

:J:.:::i

~

~

E;;::,

..Q ·-

c

CD CD

zQJ

"'·~~

~

"0
-·c
LJ.J-

~
..0-"'

~

"'

.8 .8

"' "'

"'

..c .~
u..c
u

"'

-~

:.:;

Uu..

0

c

~

"' c

....J

:5~

->- "'
c

0 0

c

.~

"'

..0

.cE

0.

"'
0
~u
0 ~

0

"'

~ ~

c uo<so

-c

0

>- c
c "'

"'·o."O

2 Vl
o=
-u-

-.;:::

"'
"0
QJ

"'

"'0

QJo

Qi

>-

-;;;

u

~ 0

:J

QJ

u

Vl

<"'

0

"0

E~

000

li1t-..

N

,..-

li1

,..-

..;-

'1:

ODD.
00

"¢N

li1

li1N

,..-

z c

tU

c.
><

~

0

z

0

z

0

c<..

.;,

co

,;.,

c<..

N

..

0

li1
N

N

::

N

N

1)1)

:I

Q
0

c

c

"'c0

z

.~

tU
Cl.

3:

.£

I

~

Q:;

Q

> QJ
>c ~

>-

·-

c

:J

E

3:
QJ

:I

0

u

u

z

~

c QJ
- >
N-

g

0oi"'

~ ~
Vl LJ.J

216

."t:

QJ

QJ~

QJ
Vlz
QJ
-

>

"'X
1-

~

·.;::;

QJ

0

"'

o(l~

I-

- "'
3:
~
QJ

"'ro

~

OD

~

c
:J c

~

~

U"i

.:0:

"'QJ

~

-;;; 3:

..c

Comment

<(

QJ

"'

OD

"'~
X
-

u

0
1-U

::J -~

QJ

r:r:c...

/NT

1 STUD

ANIM PROB 3(3) 1982

First, the unanimous house Committee boldly declared that laboratory animals deserve the care and protection of
"a strong and enlightened public" (H.
Rep. 91-1651, 91st Cong., reprinted in
(1970) U.S. Code Cong. & Ad News 5103,
1504). Second, congress expanded the
definition of "adequate veterinary care"
to include "appropriate use" of pain-relieving drugs during "actual research
and experimentation" (84 Stat. 1560,
Sec. 14). Further, every research facility
would not be required "to show annually"
in a report to the Secretary of Agriculture
that "professionally acceptable standards"
of care are followed in the administration of pain-relieving drugs (84 Stat .
1560, Sec. 14).
Thus, the "good faith" of the 1966
Act was replaced in 1970 by an Annual
Reporting system that had at least two
important functions: (1) to provide researchers with a means to demonstrate
that pain-relieving drugs are used appropriately and in accordance with professional standards, and (2) to further
"enlighten" the public about the use of
animals in biomedical research. To be
sure, the researcher still "holds the key"
to the laboratory door, but by virtue of
the 1970 amendments, that door was intended to have a "window" in it.
However, administration of the Reporting System is flawed to the extent
that neither of these two goals can be
met at present. Without adequate definitions of "pain," "distress," and "routine
procedures," researchers cannot be said
"to show" that pain-relieving drugs are
used appropriately. Researcher's parroting of stock phrases supplied by APHIS
to explain withholding of pain-relieving
drugs compounds the problem.
The Reporting System's secondary
goal-to "enlighten" the public-is also hampered by these flaws. As long as
key terms remain undefined, data gathered from Annual Reports will remain
unreliable and misleading. Explanations
for withholding of drugs could provide
/NT 1 STUD ANIM PROB 3(3) 1982

the public with important information
about how animals are used in research.
Instead, the mere repetition of stock
phrases reveals little of substance.
Nearly 12 years after passage of the
amendment, the USDA has not set any
standards or guidelines for terms as
crucial to the Reporting System as "pain"
and "distress" (9 CFR Sec. 1.1(a)-(rr); VS
Memo. 595.19 (1975)). Researchers can
hardly be expected to demonstrate that
pain-relieving drugs have been used in
"painful experimentation" if there is no
generally accepted definition of what a
painful experiment is. This analysis clearly
reveals that researchers performing similar procedures on similar test animals
apply different and conflicting standards
to determine pain or distress, and categorize animals differently on Annual Report forms, according to their own definitions. The result is that statistical data
derived from Annual Reports are unreliable and cannot accurately reflect the
use of animals in research.
The current state of scientific knowledge does not permit the setting of an
all-encompassing, definitive standard
for "pain" and "distress." Nevertheless,
changes in regulations and guidelines
can enhance the reliability and value of
the Reporting System. The term "routine
procedures" is also a crucial one in the
Reporting scheme, for any procedure
deemed to be "routine" is automatically
exempt from all reporting requirements.
(This procedure, in addition to the fact that
rats and mice are excluded from thereporting requirements, explains why APHIS
figures are so low.) The study by The Humane Society of the U.S. has revealed
that, while some definition has been
given this term, "routine,'~ it is inadequate
to assure uniform application. Indeed,
the examples discussed earlier show that
even among APHIS officials, there is disagreement as to whether some common
test procedures are "routine" or not.
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The 1970 Animal Welfare Act amendments direct that the Secretary of Agriculture "shall require" every research
facility "to show" that pain-relieving
drugs are used appropriately and in
compliance with professionally acceptable standards. In practice, however,
for nearly one-third of all animals used
in painful research, no explanation (or
an inadequate explanation) is provided.
APHIS actually exacerbates this problem by encouraging research facilities to
use stock explanatory phrases from the
APHIS instructional memorandum that
are legally inadequate.
Without information as to what
kind of product is being tested, and in
what way, the use of the suggested explanation is not a "showing," but, rather,
a mere statement. For legal purposes,
stating is simply alleging, while showing
consists of the disclosure of facts. "To
show" means "to make apparent or clear
by evidence, illustration or other means"
(Kenyon vs. Crane, 120 F. 2d, 380 (1941 )).
It has also been said that "showing" is
more than a bare assertion; rather, it
consists of special explanations and reasons (Speer vs. Desrosiers 361 So. 2d 722,
723 (1978)).
For example, the phrase "testing of
toxic products required by FDA" is merely
an assertion. It is not an explanation, as
it does not tie a specific legal requirement of the Food, Drug and Cosmetic Act
to the particular research activity of the
registrant. Without such additional information, there is no "showing" and
APHIS is unable to know whether the
Animal Welfare Act is being complied
with or not.
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Conclusions
If the reporting element of the Animal Welfare Act is to be properly enforced, APHIS will have to take the following actions.
First, APHIS must issue clear definitions of "pain" and "distress." It is suggested that an experimental procedure
should be deemed to involve pain or distress if it includes induction of any pathological state, administration of toxic
substances or substances in toxic doses,
long-term physical restraint, aversive
training procedures, or major operative
procedures such as surgery and induction of physical trauma. While this may
not cover all of the procedures that may
involve "pain and distress," it at least
gives substantially more guidance to the
individual who must complete the Annual
Report.
Second, APHIS should add a further
explanatory section to the definition of
"routine procedures." Such procedures
may still include injections, tatooing,
and blood sampling, but should specifically exclude those procedures where, for
example, an injection may lead to the induction of a pathological state.
Third, APHIS should require additional information from those who do not
use pain-relieving drugs. For example, research facilities should be asked to describe the type of experimental procedure
(e.g., ocular toxicity, carcinogen testing,
routine batch testing) and state how
administration of pain-relieving drugs
would have adversely affected the objectives of the research.
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Andrew N. Rowan
On November 23, 1981, in a Maryland District Court, Dr. Edward Taub
was found guilty under a Maryland state
anti-cruelty statute of not providing adequate veterinary care for 6 of the 17
monkeys confiscated from his laboratory
2 months earlier. The case has received
extensive press coverage and has also
caused widespread alarm in the scientific community. According to Science
(274:121, 1981 ), "scientists throughout
the country have been shocked by the
Taub case, initially perceiving it as a bid
by antivivisectionists to procure a court
ruling against animal experimentation."
Taub himself has fostered this impression and has drawn a false analogy between his predicament ("victimization")
and the persecution of scientists by rei igious authorities in the middle ages.
While the case has received extensive coverage in both scientific and animal welfare publications, there are a
number of issues that have been glossed
over or that have not been addressed at
all. Also, most accounts have only concentrated on the events from May to
November, 1981. There are some earlier
incidents that should be included in the
story for a full understanding of its ramifications.

ed under the supervision of Dr. A.). Berman in New York and involved a study of
the monkey's use of deafferentated limbs
under various conditions (e.g., Science
128:842-843, 1958; Exp Neural 7: 305-315,
1963). In the course of his work it was
demonstrated that monkeys:
1. Can use a limb in a purposeful
manner in the absence of sensory feedback, thereby refuting the general belief
at the time.
2. Learn not to use the deafferentated limb and that this learned response
can be prevented by physical restraint
of the limb.
3. Can overcome some of the effects
of deafferentation even when the dorsal
roots are cut before birth.
4. Can learn to use deafferentated
limbs even when blinded (see Science
799:960-961' 1978).
5. Can use deafferentated limbs
only clumsily but are still capable of
performing difficult movements such as
picking up raisins between thumb and
forefinger.

Dr. Taub moved to the Institute for
Behavioral Research (I BR) in 1968. He
has been Director and chief investigator
of I BR's Behavioral Biology Center since
1970. Shortly after this, he received
Background and Events
funds from the National Institute of
Leading to the Trial
Mental Health (NIMH) to pursue research
At the time of his being charged on the "effects of somatosensory deafwith cruelty, Dr. Taub, a research psy- ferentation." In 1977, the funding agenchologist, had been doing research on cy was changed to the National Institute
deafferentated primates for more than of Neurological and Communicative Dis20 years. (The deafferentation process eases and Stroke (N I NCDS). According
involves severing the dorsal roots of the to material from the Smithsonian Scispinal nerves- the "afferent" nerves that ence Information Exchange, funding for
carry sensory input from the limbs to the the project for the 4 years from 1978 to
central nervous system. The technical 1981 amounted to $312,358.
term for this procedure is "dorsal rhizoEarly in 1977, Jean Goldenberg, a
tomy.") His early research was conduct- humane society official, visited the lab/NT
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